387068008: Terazosin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with adrenergic receptor antagonist mechanism of action (substance)\Alpha adrenergic receptor antagonist\Alpha-1 adrenergic receptor antagonist\Terazosin (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Alpha adrenergic receptor antagonist\Alpha-1 adrenergic receptor antagonist\Terazosin (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Hypotensive agent (substance)\Vasodilator (substance)\Terazosin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461246017 Terazosin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481182010 Terazosin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4497601000005118 Terazosin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Terazosin (substance)	Is a	Alpha-1 adrenergic receptor antagonist	true	Inferred relationship	Some
Terazosin (substance)	Is a	Drug allergen	false	Inferred relationship	Some
Terazosin (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Alpha-1 adrenergic receptor antagonist (disposition)	true	Inferred relationship	Some
Terazosin (substance)	Is a	Alpha adrenergic receptor antagonist	false	Inferred relationship	Some
Terazosin (substance)	Is a	Vasodilator (substance)	true	Inferred relationship	Some
Terazosin (substance)	Is a	Autonomic agent (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing terazosin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Terazosin (substance)	Inferred relationship	Some	1
Terazosin adverse reaction	Causative agent	True	Terazosin (substance)	Inferred relationship	Some	1
Allergy to terazosin (finding)	Causative agent	False	Terazosin (substance)	Inferred relationship	Some
Terazosin hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
Terazosin (as terazosin hydrochloride) 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
Terazosin (as terazosin hydrochloride) 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
terazosin 1 mg tablet + 2 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
Terazosin (as terazosin hydrochloride) 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
Terazosin hydrochloride [see chap B for generic preps]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
terazosin 1 mg tablet og 2 mg tablet og 5 mg tablet , startpakning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
terazosinhydrochlorid 1 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
Terazosin hydrochloride 2mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
Terazosin hydrochloride 5mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
Terazosin hydrochloride 10mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
terazosinhydrochlorid 1 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
terazosinhydrochlorid 2 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
terazosinhydrochlorid 5 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
terazosinhydrochlorid 10 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
Terazosin hydrochloride	Is a	False	Terazosin (substance)	Inferred relationship	Some
terazosinhydrochlorid 1 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
terazosinhydrochlorid 10 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
terazosinhydrochlorid 5 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
terazosinhydrochlorid 2 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
terazosinhydrochlorid 1 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some
Allergy to terazosin (finding)	Causative agent	True	Terazosin (substance)	Inferred relationship	Some	1
Terazosin (as terazosin hydrochloride) 5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Terazosin (substance)	Inferred relationship	Some	1
Terazosin (as terazosin hydrochloride) 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Terazosin (substance)	Inferred relationship	Some	1
Terazosin (as terazosin hydrochloride) 2 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 1 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 1 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 1 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 1 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 2 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 2 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 5 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 5 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 10 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 10 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Terazosin (substance)	Inferred relationship	Some	1
Terazosin hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Terazosin (substance)	Inferred relationship	Some
terazosinhydrochlorid 1 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 10 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 2 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Terazosin (substance)	Inferred relationship	Some	1
Terazosin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 5 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Terazosin (substance)	Inferred relationship	Some	1
terazosinhydrochlorid 1 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Terazosin (substance)	Inferred relationship	Some	1
Product containing only terazosin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Terazosin (substance)	Inferred relationship	Some	1
Terazosin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Terazosin (substance)	Inferred relationship	Some	1
Terazosin (as terazosin hydrochloride) 1 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Terazosin (substance)	Inferred relationship	Some	1
Terazosin (as terazosin hydrochloride) 1 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Terazosin (substance)	Inferred relationship	Some	1
Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Terazosin (substance)	Inferred relationship	Some	1
Terazosin (as terazosin hydrochloride) 5 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Terazosin (substance)	Inferred relationship	Some	1
Terazosin (as terazosin hydrochloride) 10 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Terazosin (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461246017	Terazosin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481182010	Terazosin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4497601000005118	Terazosin	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)